James T. Willerson, M.D.
The researchers, doctors and staff that dedicate each and every day to progressing the Texas Heart Institute’s (THI) mission to reduce the devastating toll of cardiovascular disease are inspiring, and the milestones we’ve reached in 2015 have been numerous. Progress and leadership in adult human stem cell therapies to treat patients with extensive coronary heart disease and heart failure continued; new genetic insights were unveiled; the vascular receptor for inflammation was identified; and improvements using catheters to treat valvular heart disease have been ongoing. THI continues to develop smaller and more effective continuous flow left ventricular assist devices, including one that may be used in children and very small adults, and work to evaluate new and improved methods for prevention and treatment of heart and vascular disease in women progressed. While this is only a small selection of 2015 accomplishments, I am proud of our successes and eager for the year ahead.